Global Medical Food Markets Report 2022: Innovation in Functional Ingredients and Increased Research Focus on Designing Specific Ingredients for Medical Food Applications
11 Nov 2022
DUBLIN, Nov. 11, 2022 /PRNewswire/ -- The "Global Medical Food Growth Opportunities" report has been added to
ResearchAndMarkets.com's offering.
This study aims to understand the role of a medical food in patients' recovery. It provides qualitative and quantitative analyses of medical food ingredients and finished products of medical food.
North America and Europe accounted for most of the market share for both medical food ingredients and finished product medical food in 2021 due to rising physician awareness and increasing medical adherence by patients. Factors supporting market growth in these regions are the expanding geriatric population, the prevalence of chronic diseases, and policymakers' growing emphasis on malnutrition management.
The US FDA defines medical food as "a food, which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation."
Medical food is interpreted as 'food for special medical purposes (FSMPs)' in several countries, including Europe, India, China, and Australia and New Zealand. In Japan, medical food is interpreted as 'food for sick'. In Canada, medical food is governed by food for special dietary use (FSDU) and infant food regulations.
Globally, the regulatory landscape for medical food is not clearly defined, even in developed economies. As medical food is not intended to prevent or treat diseases, it is not subject to the same regulatory requirements as pharmaceutical drugs.
By ingredient, the medical food market is divided into vitamins and minerals; protein ingredients (animal and plant); nutritional lipids; prebiotics; and others (amino acids and probiotics). Of these, protein ingredients held the majority share of 64.0% (2021) in the total medical food ingredients market due to the important role they play in trauma and illness recovery.
The impact of the COVID-19 pandemic is taken into account in the analysis. The pandemic induced both positive and negative changes in the medical food market. Supply chain disruptions due to the shutting down of processing facilities and other lockdown measures affected the sale of ingredients and finished medical food.
However, the negative effects were reduced to some extent due to the growing consumer awareness and research highlighting the benefits of a medical food in patients' recovery.
By type, the medical food market is fragmented into prescription and nonprescription food. Prescription medical food dominated the medical food market with a 60.0% share in 2021 due to strong demand from developed economies for use in fatal health conditions such as oncology health, critical care and trauma, cardiovascular health, diabetes health, and cognitive health. Key market participants, such as Abbott, Nestle Health Science, and Nutricia, offer vast product portfolios of prescription medical food to meet the growing demand.
By mode of administration, the medical food market is categorized into oral (food or supplement format) and enteral tube feeding. The oral mode accounted for the larger market share of 75.0% in 2021. Preference for orally administered products, ease of availability without prescriptions, and support initiatives are key factors driving demand for orally administered medical food.
By application, the medical food market is segmented into malnutrition (including oncology health, immune health, and general malnutrition); metabolic health; digestive health; critical care and trauma; diabetes health; cardiovascular health; musculoskeletal health; and cognitive and central nervous system (CNS) health. Malnutrition, metabolic disorders, digestive disorders, and critical care and trauma are the top target diseases for medical food. Brain and cognitive health remain a small segment; nevertheless, it is one of the fastest-growing application areas for medical food.
Key Topics Covered:
1. Strategic Imperatives
Why is it Increasingly Difficult To Grow?
The Strategic Imperative
The Impact of the Top 3 Strategic Imperatives on the Medical Food Industry
Growth Opportunities Fuel The Growth Pipeline Engine
2. Growth Opportunity Analysis
Scope of Analysis
Medical Food - Definition
Differences between Dietary Supplements, Medical Food, and Pharmaceutical Drugs
Segmentation
Definition by Ingredient Type
Definition by Type and Mode of Administration
Definition by Application
Value Chain
Growth Drivers
Growth Restraints
Forecast Assumptions
Impact of the COVID-19 Pandemic on the Medical Food Market
COVID-19 - Induced Market Trends
Insurance Coverage and Reimbursement Scenario
3. Growth Opportunity Analysis - Medical Food Ingredients
Role of Ingredients in Patient Recovery - Protein Ingredients
Role of Ingredients in Patient Recovery - Nutritional Lipids
Role of Ingredients in Patient Recovery - Prebiotics
Role of Ingredients in Patient Recovery - Vitamins and Minerals
Revenue Forecast
Revenue Forecast by Ingredient
Revenue Forecast Analysis by Ingredients
Revenue Forecast by Region
Revenue Forecast Analysis by Region
Competitive Environment
Competitive Product Matrix
Product Launches - Medical Food Ingredients: 2021 and 2022
Product Launches - Medical Food Ingredients: 2021
Product Launches - Medical Food Ingredients: 2020 and 2022
Product Launches - Medical Food Ingredients: 2019 and 2020
4. Growth Opportunity Analysis - Finished Product Medical Food
Prescription Medical Food - Examples
Nonprescription Medical Food - Examples
Role of Medical Food in Malnutrition Condition
Role of Medical Food in Metabolic Health
Role of Medical Food in Digestive Health
Role of Medical Food in Critical Care and Trauma
Role of Medical Food in Musculoskeletal Health
Role of Medical Food in Cognitive and CNS Health
Role of Medical Food in Diabetes Health
Role of Medical Food in Cardiovascular Health
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast by Type
Revenue Forecast Analysis by Type
Revenue Forecast by Mode of Administration
Revenue Forecast Analysis by Mode of Administration
Revenue Forecast by Region
Revenue Forecast Analysis by Region
Percent Revenue by Application and Market Penetration
Competitive Environment
Recent Acquisitions - 2019-2022
Recent Product Launches - 2019, 2020, and 2021
5. Growth Opportunity Universe
Growth Opportunity 1: Collaborative Efforts between Drug Manufacturers and Medical Food Manufacturers
Growth Opportunity 2: Promotional Activities and Wide Reimbursement Coverage
Growth Opportunity 3: Increased Research Focus on Designing Specific Ingredients for Medical Food Applications
Growth Opportunity 4: Innovation in Functional Ingredients
6. Next Steps
Companies Mentioned
Nestle Health Science
For more information about this report visit https://www.researchandmarkets.com/r/p4gqat
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.